Showing results (51-60 of 173) with videos related to

Sort By:
Pageof 18
Alimentary Pharmacology & Therapeutics|March 1, 2024
CAMP-B score predicts the risk of hepatocellular carcinoma in patients with chronic hepatitis B after HBsAg seroclearanceHye Won Lee, Terry Cheuk-Fung Yip, Vincent Wai-Sun Wong, et al.
Iscience|May 28, 2026
Harnessing artificial intelligence for pediatric health: Current trends and future opportunitiesJialin Wu, Bonan Chen, Kate Ching-Ching Chan, et al.
Clinical and Molecular Hepatology|December 11, 2025
Normal-weight MASLD: reclassification, characteristics, and adverse liver outcomes across diverse populationsSherlot Juan Song, Eileen Laureal Yoon, Vincent Wai-Sun Wong, et al.
Clinical and Experimental Medicine|May 15, 2026
Development and validation of an explainable machine learning model using routine laboratory biomarkers for identifying prevalent MASLD: Evidence from two observational studiesJialin Wu, Wenting Wei, Terry Cheuk-Fung Yip, et al.
Clinical and Molecular Hepatology|December 1, 2025
Hypothyroidism and liver-related events risk in patients with metabolic dysfunction-associated steatotic liver diseaseXinrui Jin, Sherlot Juan Song, Jimmy Che-To Lai, et al.
Respirology (Carlton, Vic.)|September 6, 2022
Respiratory admissions before and during the COVID-19 pandemic with mediation analysis of air pollutants, mask-wearing and influenza ratesFanny Wai San Ko, Louis Ho Shing Lau, So Shan Ng, et al.
Journal of Gastroenterology and Hepatology|February 8, 2020
Factors associated with improvement in MELD score after antiviral treatment in patients with chronic hepatitis BTerry Cheuk-Fung Yip, Hye Won Lee, Vincent Wai-Sun Wong, et al.
Alimentary Pharmacology & Therapeutics|August 21, 2018
Chronic kidney disease progression in patients with chronic hepatitis B on tenofovir, entecavir, or no treatmentGrace Lai-Hung Wong, Henry Lik-Yuen Chan, Yee-Kit Tse, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 17, 2017
Effects of Diabetes and Glycemic Control on Risk of Hepatocellular Carcinoma After Seroclearance of Hepatitis B Surface AntigenTerry Cheuk-Fung Yip, Vincent Wai-Sun Wong, Henry Lik-Yuen Chan, et al.
European Journal of Internal Medicine|December 8, 2020
Negligible HCC risk during stringently defined untreated immune-tolerant phase of chronic hepatitis BHye Won Lee, Young Eun Chon, Beom Kyung Kim, et al.
Pageof 18